Mangoceuticals, Inc.
corporate_fare Company Profile
Mangoceuticals, Inc. (NASDAQ:MGRX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for MGRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-01, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 16 rated 8 or above. Recent SEC coverage for MGRX spans 8-K, 10-Q, 425, 10-K.
Recent high-impact activity:
- Mangoceuticals Raises $2.5M via Subsidiary-Level Private Placement Without Diluting MGRX Common Stock
- Mangoceuticals and Nuclea Energy Mutually Terminate Reverse Merger Agreement
- Mangoceuticals Q2 2026: Cash Drops to $229K, Going Concern Warning Reiterated, Nuclea Reverse Merger Details Emerge
- Nuclea Energy to Acquire Moltex's Advanced Nuclear Tech Assets in Cash Deal
- Merger partner Nuclea signs MOU with Utah to explore nuclear test reactor site, advancing microreactor demonstration
Financial Snapshot
Short Interest & Short Volume
1.75 days to coverFINRA reported short interest of 521,424 shares in MGRX as of the September 15, 2026 settlement, a 17.6% decrease from the prior period — about 1.8 days to cover at its recent average daily volume. On October 2, 2026, 68.2% of MGRX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for MGRX, detected from its recent SEC filings · based on capital-structure filings through 2026-07-02.
Private Placement Completed · Deep Discount Pricing
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →